New combo therapy tested for tough head & neck cancer
Disease control
Completed
This study tested whether adding an immunotherapy drug called nivolumab to standard chemotherapy and radiation treatment could better control nasopharyngeal cancer. It involved 40 adults with stage II-IVB cancer to see if the combined treatment was feasible and effective. The mai…
Phase: PHASE2 • Sponsor: Sue Yom • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC